Skip to main content
TipRanks
Go Ultimate75% OFF

Senti Biosciences (SNTI) Stock Statistics & Valuation Metrics

270 Followers

Total Valuation

Senti Biosciences has a market cap or net worth of $4.36M. The enterprise value is $40.95M.

Market Cap
$4.36M
Enterprise Value
$40.95M

Share Statistics

Senti Biosciences has 31,145,390 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
31,145,390
Owned by Insiders
2.06%
Owned by Institutions
4.09%

Financial Efficiency

Senti Biosciences’s return on equity (ROE) is -10.99 and return on invested capital (ROIC) is -149.67%.

Return on Equity (ROE)
-10.99
Return on Assets (ROA)
-1.20
Return on Invested Capital (ROIC)
-149.67%
Return on Capital Employed (ROCE)
-1.71
Revenue Per Employee
564.103
Profits Per Employee
-1.58M
Employee Count
39
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Senti Biosciences is -0.08. Senti Biosciences’s PEG ratio is -0.00.

PE Ratio
-0.08
PS Ratio
79.28
PB Ratio
-1.28
Price to FCF
-0.11
Price to Operating Cash Flow
-0.11
PEG Ratio
-0.00

Income Statement

In the last 12 months, Senti Biosciences had revenue of 22.00K and earned -61.44M in profits. Earnings per share was -2.73.

Revenue
22.00K
Gross Profit
-3.62M
Operating Income
-63.73M
Pretax Income
-61.44M
Net Income
-61.44M
EBITDA
-57.80M
Earnings Per Share (EPS)
-2.73

Cash Flow

In the last 12 months, operating cash flow was -38.05M and capital expenditures 0, giving a free cash flow of -38.05M billion.

Operating Cash Flow
-38.05M
Free Cash Flow
-38.05M
Free Cash Flow per Share
-1.22

Dividends & Yields

Senti Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-872.66%
Earnings Yield
-1136.72%

Stock Price Statistics

Beta
2.12
52-Week Price Change
-92.18%
50-Day Moving Average
0.26
200-Day Moving Average
0.67
Relative Strength Index (RSI)
33.03
Average Volume (3m)
2.64M

Important Dates

Senti Biosciences upcoming earnings date is ―, TBA (Not Confirmed).

Last Earnings Date
Nov 12, 2026
Next Earnings Date
―
Ex-Dividend Date
―

Financial Position

Senti Biosciences as a current ratio of 1.67, with Debt / Equity ratio of 516.93%

Current Ratio
1.67
Quick Ratio
1.67
Debt to Market Cap
0.00
Net Debt to EBITDA
-0.22
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Senti Biosciences has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Senti Biosciences EV to EBITDA ratio is -0.39, with an EV/FCF ratio of -0.48.

EV to Sales
329.52
EV to EBITDA
-0.39
EV to Free Cash Flow
-0.48
EV to Operating Cash Flow
-0.48

Balance Sheet

Senti Biosciences has $6.46M in cash and marketable securities with $20.23M in debt, giving a net cash position of -$13.76M billion.

Cash & Marketable Securities
$6.46M
Total Debt
$20.23M
Net Cash
-$13.76M
Net Cash Per Share
-$0.44
Tangible Book Value Per Share
-$0.11

Margins

Gross margin is -2736.36%, with operating margin of -102761.82%, and net profit margin of -90116.36%.

Gross Margin
-2736.36%
Operating Margin
-102761.82%
Pretax Margin
-90116.36%
Net Profit Margin
-90116.36%
EBITDA Margin
-85405.45%
EBIT Margin
-91136.36%

Analyst Forecast

The average price target for Senti Biosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
―
EPS Growth Forecast
80.28%

Scores

Smart Score
―
AI Score
42